-
Geographical and Temporal Variations in Availability of National Price Negotiated Novel Anticancer Drugs: A Spatial Statistical Study Based on Two Cross-Sectional Datasets in China
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States
Mar 10, 2025, 14:00 PM -
Evaluating Attributes of Non-Oncology Orphan Approvals From 2015-2024
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Reference and Biosimilar G-CSF As Primary Prophylaxis in DLBCL
Mar 10, 2025, 14:00 PM -
Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Robot-Assisted and Laparoscopic Radical Nephrectomy Versus Open Radical Nephrectomy in the Treatment of Renal Cell Carcinoma
Mar 10, 2025, 14:00 PM -
Using Machine Learning to Estimate Perceptions and Future Prescribing Intentions of Health Care Providers: A Novel Application of Integrated Primary and Secondary Data in Understanding HCP Decision-Making
Mar 10, 2025, 14:00 PM -
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM -
Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D
Mar 10, 2025, 14:00 PM -
Application of Prevalent New-User Cohort Designs to a Claims Data Study of Incidence of Nutritional Deficiency in People With Diabetes Using GLP-1 Receptor Agonists
Mar 10, 2025, 14:00 PM -
Evaluation of Marginal Healthcare Expenditures and Health-related Quality of Life in Multiple Sclerosis with a Bayesian Quantile Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling
Mar 10, 2025, 14:00 PM -
Progression-Free Survival and Objective Response Rates As Surrogate Endpoints for Overall Survival Among Patients With ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving ROS1 Tyrosine Kinase Inhibitors
Mar 10, 2025, 14:00 PM -
Heterogeneity in Preferences for HIV Self-Testing Among Ugandan Men
Mar 10, 2025, 14:00 PM -
Barriers to CAR-T Therapy Access in the U.S.: A County-Level Analysis of Proximity and Sociodemographic Factors
Mar 10, 2025, 14:00 PM -
Hematologist-Oncologist Preferences for Treating Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) using Tyrosine Kinase Inhibitors in Combination with Chemotherapy: A Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data
Mar 10, 2025, 14:00 PM -
AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status
Mar 10, 2025, 14:00 PM -
A Conceptual Epidemiological and Economic Model to Predict Obesity in Low- and Middle-Income Countries: A Meta-Synthesis
Mar 10, 2025, 14:00 PM -
Quantifying the Financial Burden of HbA1c Levels: A Retrospective Single-Center Analysis of Healthcare Costs in South Korean Diabetes Patients.
Mar 10, 2025, 14:00 PM
